275 related articles for article (PubMed ID: 30973110)
21. Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction.
Chen ML; Doddi A; Royer J; Freschi L; Schito M; Ezewudo M; Kohane IS; Beam A; Farhat M
EBioMedicine; 2019 May; 43():356-369. PubMed ID: 31047860
[TBL] [Abstract][Full Text] [Related]
22. Antitubercular activity of Ru (II) isoniazid complexes.
Aguiar Id; Tavares A; Roveda AC; da Silva AC; Marino LB; Lopes ÉO; Pavan FR; Lopes LG; Franco DW
Eur J Pharm Sci; 2015 Apr; 70():45-54. PubMed ID: 25638418
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro antitubercular activity of pyridine analouges against the resistant Mycobacterium tuberculosis.
Patel H; Chaudhari K; Jain P; Surana S
Bioorg Chem; 2020 Sep; 102():104099. PubMed ID: 32711084
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a membrane hybridization array for detection of Mycobacterium tuberculosis complex and resistance to isoniazid and rifampin in sputum specimens, mycobacterial liquid cultures, and clinical isolates.
Chen CJ; Yang YC; Huang HH; Chang TC; Lu PL
Kaohsiung J Med Sci; 2019 Oct; 35(10):615-623. PubMed ID: 31433118
[TBL] [Abstract][Full Text] [Related]
25. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents.
Soares A; Estevao MS; Marques MMB; Kovalishyn V; Latino DARS; Aires-de-Sousa J; Ramos J; Viveiros M; Martins F
Med Chem; 2017; 13(5):439-447. PubMed ID: 28185538
[TBL] [Abstract][Full Text] [Related]
28. High-resolution melting analysis for molecular detection of multidrug resistance tuberculosis in Peruvian isolates.
Galarza M; Fasabi M; Levano KS; Castillo E; Barreda N; Rodriguez M; Guio H
BMC Infect Dis; 2016 Jun; 16():260. PubMed ID: 27278526
[TBL] [Abstract][Full Text] [Related]
29. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice.
Vilchèze C; Kim J; Jacobs WR
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29298757
[TBL] [Abstract][Full Text] [Related]
30. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
[TBL] [Abstract][Full Text] [Related]
31. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar.
Rivoire N; Ravololonandriana P; Rasolonavalona T; Martin A; Portaels F; Ramarokoto H; Rasolofo Razanamparany V
Int J Tuberc Lung Dis; 2007 Jun; 11(6):683-8. PubMed ID: 17519102
[TBL] [Abstract][Full Text] [Related]
33. Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis.
Chen T; Li Q; Guo L; Yu L; Li Z; Guo H; Li H; Zhao M; Chen L; Chen X; Zhong Q; Zhou L; Wu T
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():659-65. PubMed ID: 26478357
[TBL] [Abstract][Full Text] [Related]
34. [Multicenter evaluation of the indirect nitrate reductase assay for the rapid detection of multidrug-resistant tuberculosis].
Çoban AY; Taştekin B; Uzun M; Kalaycı F; Ceyhan İ; Biçmen C; Albay A; Sığ AK; Özkütük N; Sürücüoğlu S; Özkütük A; Esen N; Albayrak N; Aslantürk A; Sarıbaş Z; Alp A
Mikrobiyol Bul; 2016 Jan; 50(1):140-6. PubMed ID: 27058338
[TBL] [Abstract][Full Text] [Related]
35. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
[TBL] [Abstract][Full Text] [Related]
36. Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.
Karunanidhi S; Chandrasekaran B; Karpoormath R; Patel HM; Kayamba F; Merugu SR; Kumar V; Dhawan S; Kushwaha B; Mahlalela MC
Bioorg Chem; 2021 Oct; 115():105133. PubMed ID: 34329993
[TBL] [Abstract][Full Text] [Related]
37. Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
Igarashi Y; Chikamatsu K; Aono A; Yi L; Yamada H; Takaki A; Mitarai S
Diagn Microbiol Infect Dis; 2017 Dec; 89(4):276-281. PubMed ID: 28974394
[TBL] [Abstract][Full Text] [Related]
38. Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia.
Elhassan MM; Hemeg HA; Elmekki MA; Turkistani KA; Abdul-Aziz AA
Infect Disord Drug Targets; 2017; 17(1):14-23. PubMed ID: 27848902
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
40. Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.
Ho J; Jelfs P; Sintchencko V
J Antimicrob Chemother; 2013 Dec; 68(12):2915-20. PubMed ID: 23838950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
